3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Genitourinary
1
Endocrine
1
CNS
1
Conditions
Sarcoma
111
Osteosarcoma
41
Sarcoma, Ewing
30
Rhabdomyosarcoma
28
Melanoma
28
Neuroblastoma
21
Glioblastoma
18
Bone Neoplasms
18
Rhabdoid Tumor
17
Lymphoma, Non-Hodgkin
17
Gliosarcoma
16
Neoplasms
15
Neoplasm Metastasis
15
Liposarcoma
15
Breast Neoplasms
15
Wilms Tumor
14
Ovarian Neoplasms
14
Glioma
14
Medulloblastoma
13
Gastrointestinal Stromal Tumors
13
Carcinoma, Non-Small-Cell Lung
13
Stomach Neoplasms
12
Leiomyosarcoma
12
Hepatoblastoma
12
Colorectal Neoplasms
12
Sarcoma, Synovial
11
Ependymoma
11
Chordoma
11
Carcinoma, Renal Cell
11
Neurofibrosarcoma
10
Interventions
entrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Nephroma, Mesoblastic
×
Sarcoma
×
Clear all
NCT02650401
2026-03-25
STARTRK-NG
Hoffmann-La Roche
Phase 1/2
Active not recruiting
69 enrolled
1 FDA